The MIT-spinoff commercializing a clinical grade, heart monitoring “Smart Bra” for cardiovascular disease represents the first Femtech investment outside of the reproductive health and breast cancer space CAMBRIDGE, Mass., March 12, 2020-- Health technology company Bloomer Tech (Bloomer) today announced that it has raised $3M in a Series Seed funding round. Material Impact, who led the round, was joined by One Brave Idea and several prominent Angels that include John Abele, co-founder of Boston Scientific. Bloomer is tackling the leading cause of death in women with the world’s first electrocardiogram device that looks and feels like a bra.